D.C. Circuit Expedites E-Liquid Maker’s Bid For Review Of FDA Ban
WASHINGTON, D.C. — The D.C. Circuit U.S. Court of Appeals on April 24 ordered an expedited briefing schedule of a California-based e-liquid manufacturer’s petition for review of a Food and Drug...To view the full article, register now.
Already a subscriber? Click here to view full article